KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Diluted Average): 2017-2025

Historic Shares Outstanding (Diluted Average) for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $501.2 million.

  • Elanco Animal Health's Shares Outstanding (Diluted Average) rose 0.70% to $501.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.2 million, marking a year-over-year increase of 0.70%. This contributed to the annual value of $497.3 million for FY2024, which is 1.02% up from last year.
  • Elanco Animal Health's Shares Outstanding (Diluted Average) amounted to $501.2 million in Q3 2025, which was up 0.22% from $500.1 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Shares Outstanding (Diluted Average) registered a high of $501.2 million during Q3 2025, and its lowest value of $486.7 million during Q1 2021.
  • Over the past 3 years, Elanco Animal Health's median Shares Outstanding (Diluted Average) value was $496.0 million (recorded in 2024), while the average stood at $496.0 million.
  • Data for Elanco Animal Health's Shares Outstanding (Diluted Average) shows a peak YoY rose of 20.50% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Shares Outstanding (Diluted Average) stood at $487.2 million in 2021, then climbed by 0.23% to $488.3 million in 2022, then climbed by 0.82% to $492.3 million in 2023, then grew by 1.02% to $497.3 million in 2024, then climbed by 0.70% to $501.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $501.2 million for Q3 2025, versus $500.1 million for Q2 2025 and $499.1 million for Q1 2025.